...
首页> 外文期刊>Intensive care medicine >Endotracheal suctioning versus minimally invasive airway suctioning in intubated patients: a prospective randomised controlled trial.
【24h】

Endotracheal suctioning versus minimally invasive airway suctioning in intubated patients: a prospective randomised controlled trial.

机译:插管患者气管内吸气与微创气道吸气:一项前瞻性随机对照试验。

获取原文
获取原文并翻译 | 示例

摘要

STUDY OBJECTIVE: Endotracheal suctioning in intubated patients is routinely applied in most ICUs but may have negative side effects. We hypothesised that on-demand minimally invasive suctioning would have fewer side effects than routine deep endotracheal suctioning, and would be comparable in duration of intubation, length of stay in the ICU, and ICU mortality. DESIGN: Randomised prospective clinical trial. SETTING: In two ICUs at University Hospital Groningen, the Netherlands. PATIENTS: Three hundred and eighty-three patients requiring endotracheal intubation for more than 24 h. INTERVENTIONS: Routine endotracheal suctioning (n=197) using a 49-cm suction catheter was compared with on-demand minimally invasive airway suctioning (n=186) using a suction catheter only 29 cm long. MEASUREMENTS AND RESULTS: No differences were found between the routine endotracheal suctioning group and the minimally invasive airway suctioning group in duration of intubation [median (range) 4 (1-75) versus 5 (1-101) days], ICU-stay [median (range) 8 (1-133) versus 7 (1-221) days], ICU mortality (15% versus 17%), and incidence of pulmonary infections (14% versus 13%). Suction-related adverse events occurred more frequently with RES interventions than with MIAS interventions; decreased saturation: 2.7% versus 2.0% (P=0.010); increased systolic blood pressure 24.5% versus 16.8% (P<0.001); increased pulse pressure rate 1.4% versus 0.9% (P=0.007); blood in mucus 3.3% versus 0.9% (P<0.001). CONCLUSIONS: This study demonstrated that minimally invasive airway suctioning in intubated ICU-patients had fewer side effects than routine deep endotracheal suctioning, without being inferior in terms of duration on intubation, length of stay, and mortality.
机译:研究目的:在大多数ICU中,通常对插管患者进行气管内吸痰,但可能会有不良副作用。我们假设按需微创抽吸术比常规深层气管插管术具有更少的副作用,并且在插管持续时间,在ICU中的停留时间和ICU死亡率方面具有可比性。设计:随机前瞻性临床试验。地点:荷兰格罗宁根大学医院的两个重症监护室。患者:383名需要气管插管持续超过24小时的患者。干预措施:将使用49厘米抽吸导管的常规气管内抽吸(n = 197)与仅29厘米长的抽吸导管按需微创气道抽吸(n = 186)进行了比较。测量和结果:在气管插管持续时间[中位(范围)4(1-75)天与5(1-101)天],ICU停留时间[[中位(范围)8(1-133)天与7(1-221)天],ICU死亡率(15%对17%)以及肺部感染的发生率(14%对13%)。 RES干预比MIAS干预更频繁地发生与抽吸相关的不良事件。饱和度降低:2.7%和2.0%(P = 0.010);收缩压增加了24.5%,而血压升高了16.8%(P <0.001);脉压率从0.9%提高到1.4%(P = 0.007);粘液中的血液含量为3.3%和0.9%(P <0.001)。结论:这项研究表明,在插管ICU患者中进行微创气道抽吸术比常规深层气管内抽吸术具有更少的副作用,并且在插管持续时间,住院时间和死亡率方面均不逊色。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号